🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Bevacizumab

    The First People's Hospital of Lianyungang

    Malignant Pleural Effusion

    phase 2 small molecule active

    1 trial

  2. Bevacizumab

    United Therapeutics Europe Ltd

    Recurrent Glioblastoma

    phase 2 mab active

    1 trial

  3. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Colorectal Neoplasms

    phase 2 small molecule terminated

    1 trial

  4. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  5. Bevacizumab

    United Therapeutics Europe Ltd

    Metastatic Melanoma

    phase 2 mab completed

    1 trial

  6. Bevacizumab Biosimilar IBI305

    The First People's Hospital of Lianyungang

    Post-orthotopic Liver Transplantation

    phase 2 small molecule active

    1 trial

  7. Bevacizumab combined with Oxaliplatin and TAS-102

    The First People's Hospital of Lianyungang

    Advanced Colorectal Cancer

    phase 2 small molecule active

    1 trial

  8. Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  9. Bevacizumab/Irinotecan

    Solid Biosciences

    Glioblastoma

    phase 2 small molecule completed

    1 trial

  10. Bexmarilimab

    Lacuna Pharma Pty Ltd

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  11. Bezuclastinib Tablets (Formulation A)

    Cogent Biosciences

    SSM

    phase 2 small molecule active

    1 trial

  12. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Diabetic Peripheral Neuropathy

    phase 2 small molecule active

    1 trial

  13. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Chronic Peripheral Neuropathy Pain in Diabetics

    phase 2 small molecule terminated

    1 trial

  14. Bisphosphocin Nu-3

    Lakewood-Amedex Biotherapeutics

    Diabetic Foot Infections

    phase 2 small molecule completed

    1 trial

  15. Blautix

    4D Molecular Therapeutics

    Irritable Bowel Syndrome

    phase 2 mab completed

    1 trial

  16. Blinatumomab

    BEONE MEDICINES AUS PTY LTD

    B Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  17. Blinatumomab

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  18. Blinatumomab

    Amgen

    B Precursor Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  19. Blinatumomab

    Takeda

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

    phase 2 mab active

    1 trial

  20. Blinatumomab

    The First People's Hospital of Lianyungang

    B-cell Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  21. Blinatumomab SC2

    Amgen

    Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+) B-Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  22. Blinatumomab plus Reduced-dose Chemotherapy

    The First People's Hospital of Lianyungang

    Precursor B-Cell Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  23. Bosutinib, Bosutinib, Bosulif 100 mg film-coated tablets, Bosulif 500 mg film-coated tablets, Bosulif 100 mg film-coated tablets, Bosulif 100 mg film-coated tablets, Bosulif 500 mg film-coated tablets

    Disc Medicine

    Chronic Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  24. Braftovi 75 mg hard capsules, LIBTAYO 350 mg concentrate for solution for infusion., Mektovi 15 mg film-coated tablets, Fianlimab, Braftovi 50 mg hard capsules

    Disc Medicine

    Melanoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources